Warning: The NCBI web site requires JavaScript to function. more...
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer.
Howe LR.
Breast Cancer Res. 2007;9(4):210. Review.
Related citations
The role of COX-2 inhibition in breast cancer treatment and prevention.
Arun B, Goss P.
Semin Oncol. 2004 Apr;31(2 Suppl 7):22-9. Review.
Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.
Davies G, Martin LA, Sacks N, Dowsett M.
Ann Oncol. 2002 May;13(5):669-78. Review.
Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E, Tang XM, Gwyn K, Sahin A, Wathen K, Sinicrope FA.
Cancer Res. 2002 Mar 15;62(6):1676-81.
Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
Chell S, Kaidi A, Williams AC, Paraskeva C.
Biochim Biophys Acta. 2006 Aug;1766(1):104-19. Epub 2006 May 23. Review. Erratum in: Biochim Biophys Acta. 2007 Jun;1775(2):341. Kadi, Abderrahmane [corrected to Kaidi, Abderrahmane].
COX-2 inhibitors for the prevention of breast cancer.
Howe LR, Dannenberg AJ.
J Mammary Gland Biol Neoplasia. 2003 Jan;8(1):31-43. Review.
A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.
Semin Oncol. 2002 Jun;29(3 Suppl 11):111-9. Review.
Combination chemoprevention of HER2/neu-induced breast cancer using a cyclooxygenase-2 inhibitor and a retinoid X receptor-selective retinoid.
Brown PH, Subbaramaiah K, Salmon AP, Baker R, Newman RA, Yang P, Zhou XK, Bissonnette RP, Dannenberg AJ, Howe LR.
Cancer Prev Res (Phila). 2008 Aug;1(3):208-14.
Prognostic impact of cyclooxygenase-2 in breast cancer.
Denkert C, Winzer KJ, Hauptmann S.
Clin Breast Cancer. 2004 Feb;4(6):428-33. Review.
Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy.
Sarkar FH, Adsule S, Li Y, Padhye S.
Mini Rev Med Chem. 2007 Jun;7(6):599-608. Review.
Cyclooxygenase-2: a potential target in breast cancer.
Wang D, Dubois RN.
Semin Oncol. 2004 Feb;31(1 Suppl 3):64-73. Review.
The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
Kong G, Kim HT, Wu K, DeNardo D, Hilsenbeck SG, Xu XC, Lamph WW, Bissonnette R, Dannenberg AJ, Brown PH.
Cancer Res. 2005 Apr 15;65(8):3462-9.
Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ.
Endocr Relat Cancer. 2001 Jun;8(2):97-114. Review.
Targeting cyclooxygenase-2 for prevention and therapy of colorectal cancer.
Sinicrope FA.
Mol Carcinog. 2006 Jun;45(6):447-54. Review.
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung.
Harris RE.
Inflammopharmacology. 2009 Apr;17(2):55-67. Review.
Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
Richards JA, Petrel TA, Brueggemeier RW.
J Steroid Biochem Mol Biol. 2002 Feb;80(2):203-12. Review.
Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM.
J Environ Pathol Toxicol Oncol. 2002;21(2):193-201. Review.
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors.
Harris RE, Beebe-Donk J, Alshafie GA.
BMC Cancer. 2006 Jan 30;6:27.
Cyclooxygenases in hepatocellular carcinoma.
Cervello M, Montalto G.
World J Gastroenterol. 2006 Aug 28;12(32):5113-21. Review.
Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer.
Hwang D, Scollard D, Byrne J, Levine E.
J Natl Cancer Inst. 1998 Mar 18;90(6):455-60.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on